GZMB

From Wikipedia, the free encyclopedia


Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
PDB rendering based on 1fq3.
Available structures: 1fq3, 1iau
Identifiers
Symbol(s) GZMB; HLP; CTLA1; CCPI; CGL-1; CGL1; CSP-B; CSPB; CTSGL1; SECT
External IDs OMIM: 123910 MGI109267 HomoloGene20876
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 3002 14939
Ensembl ENSG00000100453 ENSMUSG00000015437
Uniprot P10144 Q3TIP3
Refseq NM_004131 (mRNA)
NP_004122 (protein)
NM_013542 (mRNA)
NP_038570 (protein)
Location Chr 14: 24.17 - 24.17 Mb Chr 14: 55.21 - 55.22 Mb
Pubmed search [1] [2]

Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1), also known as GZMB, is a human gene.

Cytolytic T lymphocytes (CTL) and natural killer (NK) cells share the remarkable ability to recognize, bind, and lyse specific target cells. They are thought to protect their host by lysing cells bearing on their surface 'nonself' antigens, usually peptides or proteins resulting from infection by intracellular pathogens. The protein encoded by this gene is crucial for the rapid induction of target cell apoptosis by CTL in cell-mediated immune response.[1]

[edit] See also

[edit] References

[edit] Further reading

  • Trapani JA (1996). "Target cell apoptosis induced by cytotoxic T cells and natural killer cells involves synergy between the pore-forming protein, perforin, and the serine protease, granzyme B.". Australian and New Zealand journal of medicine 25 (6): 793-9. PMID 8770355. 
  • Cohen GM (1997). "Caspases: the executioners of apoptosis.". Biochem. J. 326 ( Pt 1): 1-16. PMID 9337844. 
  • Trapani JA, Sutton VR (2004). "Granzyme B: pro-apoptotic, antiviral and antitumor functions.". Curr. Opin. Immunol. 15 (5): 533-43. PMID 14499262.